<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7707449</journal-id>
<journal-id journal-id-type="pubmed-jr-id">656</journal-id>
<journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol.</journal-id>
<journal-title-group>
<journal-title>Annals of neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31591744</article-id>
<article-id pub-id-type="pmc">7210715</article-id>
<article-id pub-id-type="doi">10.1002/ana.25610</article-id>
<article-id pub-id-type="manuscript">NIHMS1584382</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>T-lymphocytes and Cytotoxic Astrocyte Blebs Correlate Across Autism Brains</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>DiStasio</surname>
<given-names>Marcello M.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nagakura</surname>
<given-names>Ikue</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nadler</surname>
<given-names>Monica J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Matthew P.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="corresp" rid="CR1">‡</xref>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Departments of Neurology and Pathology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02115, USA.</aff>
<aff id="A2"><label>2</label>Boston Children’s Hospital Intellectual and Developmental Disabilities Research Center, 300 Longwood Avenue, Boston, MA 02115, USA.</aff>
<aff id="A3"><label>3</label>Program in Neuroscience, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.</aff>
<author-notes>
<corresp id="CR1"><label>‡</label>To whom correspondence should be addressed. <underline>Contact</underline>: Matthew P. Anderson, MD, PhD, Associate Professor of Pathology, Harvard Medical School, Director of Neuropathology, Department of Pathology, Beth Israel Deaconess Medical Center Faculty, Program in Neuroscience, Harvard Medical School, Investigator, Boston Children’s Hospital Intellectual and Developmental Disabilities Research Center, Center for Life Science, 330 Brookline Ave, E/CLS-645, Boston, MA 02215, Tel: (617) 735-3202, FAX: (617) 735-3249, <email>Matthew Anderson@bidmc.harvard.edu</email></corresp>
<fn fn-type="con" id="FN1">
<p id="P1"><bold>Author Contributions:</bold> M.M.D. and M.P.A. contributed to the conception and design of the study; M.M.D., I.N., and M.J.N. and M.P.A. contributed to the acquisition and analysis of data; M.M.D. and M.P.A. contributed to drafting the text and preparing the figures.</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p id="P39"><bold>Potential Conflicts of Interest:</bold> Nothing to report.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>09</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>86</volume>
<issue>6</issue>
<fpage>885</fpage>
<lpage>898</lpage>
<!--elocation-id from pubmed: 10.1002/ana.25610-->
<abstract id="ABS1">
<sec id="S1">
<title>Objective</title>
<p id="P2">Autism spectrum disorder (ASD) affects 1 in 59 children yet, except for rare genetic causes, the etiology in most ASD remains unknown. In the ASD brain, inflammatory cytokine and transcript profiling show increased expression of genes encoding mediators of the innate immune response. We evaluated post-mortem brain tissue for adaptive immune cells and immune cell-mediated cytotoxic damage that could drive this innate immune response in the ASD brain.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">Standard neuropathology diagnostic methods including histology and immunohistochemistry were extended with automated image segmentation to quantify identified pathologic features in the postmortem brains.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">We report multifocal perivascular lymphocytic cuffs contain increased numbers of lymphocytes in ~65% of ASD compared to control brains in males and females, across all ages, in most brain regions, and in white and grey matter, and leptomeninges. CD3<sup>+</sup> T-lymphocytes predominate over CD20<sup>+</sup> B-lymphocytes and CD8<sup>+</sup> over CD4<sup>+</sup> T-lymphocytes in ASD brains. Importantly, the perivascular cuff lymphocytes numbers correlate to the quantity of astrocyte-derived round membranous blebs. Membranous blebs form as a cytotoxic reaction to lymphocyte attack. Consistent with multifocal immune cell-mediated injury at perivascular CSF-brain barriers, a subset of white matter vessels have increased perivascular space (with jagged contours) and collagen in ASD compared to control brains. CSF-brain barrier pathology is also evident at cerebral cortex pial and ventricular ependymal surfaces in ASD.</p>
</sec>
<sec id="S4">
<title>Interpretation</title>
<p id="P5">The findings suggest dysregulated cellular immunity damages astrocytes at foci along the CSF-brain barrier in ASD.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>